首页/数据集/Safety and immunogenicity of a tetravalent and bivalent SARS-CoV-2 protein booster vaccine in men

Safety and immunogenicity of a tetravalent and bivalent SARS-CoV-2 protein booster vaccine in men

NIAID Data Ecosystem2026-05-01 收录

数据链接：

https://figshare.com/articles/dataset/Safety_and_immunogenicity_of_a_tetravalent_and_bivalent_SARS-CoV-2_protein_booster_vaccine_in_men/22769732 数据链接链接失效反馈

官方服务：

资源简介：

Source Data Listing of Vaccine Related Adverse Events

应用场景：

创建时间：

2023-07-09

疫苗安全性评估

流感病毒减毒机制

Peste des Petits Ruminants (PPR) is a highly infectious disease caused by a virus of the Morbillivirus genus. The current PPR eradication effort relies mainly on the implementation of massive vaccinat

NIAID Data Ecosystem80

Assessing recombination between self-amplifying mRNA vaccines and wild-type alphaviruses in vitro and in vivo

疫苗安全性评估

病毒重组检测

GETV and SAM vaccine were co-injected subcutaneously into the hind feet of 6-10 week old female IFNAR-/-, Rag-/-, and C57BL/6J mice. Feet were harvested at various time points, and had RNA sequenced b

NIAID Data Ecosystem30

Dataset from Safety and Immunogenicity Study of GSK Biologicals' Candidate Tuberculosis Vaccine (692342) When Administered to Healthy Infants

疫苗临床试验

结核病预防

This purpose of the study is to assess the safety and immunogenicity of a GSK Biologicals' candidate tuberculosis vaccine (692342) when administered concomitantly with or after the Expanded Programme

NIAID Data Ecosystem20

ATN 064 Burk HPV DNA Dataset in Immunogenicity, Safety, Tolerability, and Behavioral Consequences of an HPV-6, -11, -16, -18 Vaccine in HIV-Infected Young Women

疫苗临床试验

HIV感染者免疫干预

Burk Lab HPV DNA data Study Description A Phase II, open-label, multi-center study that evaluated the immunogenicity, safety, tolerability, and behavioral impact of an HPV-6, -11, -16, -18 vaccine in

NIAID Data Ecosystem40

Characteristics of HVTN 502 and 503 trial participants.

疫苗临床试验

免疫基因型分析

Data shown are median values (interquartile range) unless otherwise indicated. * At time of sampling § HLA-B*27, B51, B*5701/03, B*5801 and B*8101 Characteristics of HVTN 502 and 503 trial participant

NIAID Data Ecosystem20

Safety and immunogenicity of a tetravalent and bivalent SARS-CoV-2 protein booster vaccine in men

资源简介：

相关数据集